Experts and company leadership to discuss clinical significance of indications driven by muscle atrophy and Ph2 trial design for acute ICU myopathies in older patientsRICHMOND, Calif. (BUSINESS WIRE) #aging BioAge Labs, Inc. (“BioAge”), a clinical-stage biotechnology company developing therapeutics that target th.